Huier Kangxin, a full-dose non-adjuvant vaccine by Jiangsu Ab&B Bio-Tech Co Ltd, has become the first tetravalent influenza virus subunit vaccine to receive approval for sale in China.

Located in the Chunjiang Wetland Park, the construction of the first standardized biodiversity observation station in Jiangsu province recently started.

Jiangsu YIMI Bio-tech Co Ltd, which is based in Taizhou Medical High-tech Zone, also known as Gaogang district, was recently granted a US invention patent for its liquid collection device.

The automobile industry is on the road to major expansion in the city of Taizhou.

The nylon elastomer and elastic fiber research and development project conducted by Jiangsu Haiyang Nylon New Material Co Ltd was selected to be a provincial key technology research project.

The Taizhou Medical High-tech Zone is moving up the pace of construction, with the build-out of its parks now in full swing.

The Taizhou Medical High-tech Zone is hard at work building innovative platforms to promote the commercialization of the technological achievements that are being made there.

Recently, the Amplicon-gene medical test laboratory – located in the Taizhou Medical High-tech Zone – has been approved by the College of American Pathologists (CAP).